- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07530185
Effekter av L-Tyrosin och Koffein på Prestanda hos Elitboxare (TYCAF-BOX)
Effekter av L-Tyrosin- och Koffeintillskott på Kognitiva, Fysiska och Fysiologiska Parametrar hos Elitboxare: En Randomiserad Dubbelblind Placebokontrollerad Korsningsstudie
Participants will complete six sessions, including one familiarization and baseline session followed by five experimental conditions: control (no supplementation), placebo, L-tyrosine, caffeine, and combined L-tyrosine plus caffeine. The experimental conditions will be performed in a randomized, counterbalanced crossover design with a washout period of at least 72 hours between sessions. Resting physiological and cognitive assessments will be performed during the familiarization session, while biochemical, cognitive, and boxing-specific performance assessments will be conducted before and after each experimental session.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Participants will attend six sessions in total. The first session will be used for familiarization and baseline assessments, including anthropometric measurements, resting physiological measurements, and cognitive performance testing. The remaining five sessions will consist of one control condition (no supplementation) and four randomized experimental conditions (placebo, L-tyrosine, caffeine, and combined L-tyrosine plus caffeine) administered in a randomized, counterbalanced crossover design.
Each experimental session will be separated by a washout period of at least 72 hours. During the placebo, L-tyrosine, caffeine, and combined supplementation conditions, the assigned intervention will be administered 60 minutes before exercise. No supplement will be administered during the control condition.
Before and immediately after each experimental session, venous blood samples will be collected to assess brain-derived neurotrophic factor (BDNF) and oxidative stress biomarkers, including total antioxidant status (TAS), total oxidant status (TOS), malondialdehyde (MDA), superoxide dismutase (SOD), and glutathione peroxidase (GPx). Cognitive performance will be evaluated using the computerized Stroop test, and boxing-specific physical performance will be assessed using a standardized boxing simulation protocol. Heart rate and rating of perceived exertion (RPE) will also be recorded during the exercise protocol.
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Halil UÇAR
- Telefonnummer: +90 5462921133
- E-post: halil.ucar@inonu.edu.tr
Studieorter
-
-
-
Erzurum, Turkiet (Türkiye)
- Rekrytering
- Ataturk University Faculty of Sport Sciences
-
Kontakt:
- Halil UÇAR
- Telefonnummer: +90 5462921133
- E-post: halil.ucar@inonu.edu.tr
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
Male elite boxers aged ≥18 years At least 8 years of boxing training experience Active participation in national or international competitions Regular training schedule No injury or illness affecting performance
Exclusion Criteria:
Use of nutritional supplements or stimulants within the last 4 weeks Any cardiovascular, metabolic, or neurological disorder Current injury or musculoskeletal limitation Smoking or excessive caffeine intake Failure to comply with study procedures
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Grundläggande vetenskap
- Tilldelning: Randomiserad
- Interventionsmodell: Crossover tilldelning
- Maskning: Dubbel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Placebo-jämförare: Placebo
Participants receive placebo condition. |
Placebo solution matched in taste and volume to active supplements. |
|
Experimentell: L-tyrosine
Participants receive L-tyrosine condition. |
L-tyrosine at 150 mg/kg body weight administered 60 minutes before exercise. |
|
Experimentell: Caffeine
Participants receive caffeine condition. |
Caffeine at 5 mg/kg body weight administered 60 minutes before exercise. |
|
Experimentell: Combined
Participants receive combined supplementation condition. |
Combined L-tyrosine (150 mg/kg) and caffeine (5 mg/kg) administered 60 minutes before exercise. |
|
Inget ingripande: Control
Participants complete the experimental protocol without receiving placebo or active supplementation. Baseline cognitive, physiological, and physical performance assessments are performed under the control condition. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Stroop Test Performance
Tidsram: up to 12 weeks
|
Cognitive performance assessed using the Stroop test, including reaction time and accuracy. |
up to 12 weeks
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
BDNF Levels
Tidsram: up to 12 weeks
|
Serum brain-derived neurotrophic factor levels measured before and after exercise. |
up to 12 weeks
|
|
Oxidative Stress Markers
Tidsram: up to 12 weeks
|
Serum levels of total antioxidant status (TAS), total oxidant status (TOS), malondialdehyde (MDA), superoxide dismutase (SOD) activity, and glutathione peroxidase (GPx) activity will be measured. |
up to 12 weeks
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- UcarPhD2026
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .